Ajanta pharma posts Q4FY23 consolidated PAT at Rs. 122.25 Cr
The company has reported total income of Rs. 918.67 crores during the period ended March 31, 2023
The company has reported total income of Rs. 918.67 crores during the period ended March 31, 2023
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
Nous-209 has been developed using the Nouscom's viral vector platform
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
Sun Pharma said had a teleconference call with the US Food and Drug Administration (USFDA) regarding a pulmonary embolism (serious adverse events) occurring at the 12 mg dose
New agreement applies to the polymers of the Medical Care series portfolio
Subscribe To Our Newsletter & Stay Updated